Global brokerage firm Goldman Sachs has turned cautious on Indian equities, downgrading its stance on the market to “marketweight”, cutting its Nifty target and warning that an “energy‑shock‑led” earnings downgrade cycle is about to unfold. The US investment bank argues that higher‑for‑longer oil prices following tensions around the Strait of Hormuz have meaningfully worsened India’s…
Stop Loss: Rs 1182Target: Rs 1,375The technical structure of Aurobindo Pharma Ltd is turning positive as the stock is approaching a breakout from a key resistance zone near 1,240. Price action has formed higher lows in recent sessions, indicating gradual accumulation. The stock is trading above its short-term moving averages, reflecting improving trend strength. Additionally,…
The Indian market closed sharply lower on Tuesday, as a late-morning selloff dragged benchmark indices to their lowest levels in more than two months. At the end of the session, the BSE Sensex declined 1065.7 points or 1.28% to close at 82,180.47, while the NSE Nifty 50 slipped lower by 353 points or 1.38%, settling…
Foreign institutional investors (FIIs) pulled out Rs 34,993 crore from Indian equities in August, their sharpest retreat this year, as US tariff shocks and weak June-quarter earnings weighed on sentiment. The outflows pushed year-to-date FII selling past Rs 1.3 lakh crore, raising concerns about India’s place in global portfolios, even as policy reforms and stronger-than-expected…